On December 9th, Innoscience (Suzhou) Technology Co., Ltd. ("Innoscience" or "the Company") successfully passed the hearing with the Hong Kong Stock Exchange (HKEX). The IPO is being jointly sponsored by China International Capital Corporation (CICC) and CMB International.
Key Milestone in the IPO Process
The HKEX IPO process typically involves several steps: application submission, hearing, roadshow, pricing, allocation announcement, gray market trading, and finally, listing.
During the hearing phase, the Listing Committee reviews the applicant's submission and evaluates its eligibility for the IPO. This comprehensive assessment ensures compliance with regulatory requirements and verifies the company’s readiness for public listing. Clearing the hearing is a significant milestone, indicating that the company is nearing the roadshow and public offering stages.
Innoscience: A Leading GaN IDM Enterprise
Founded in 2017, Innoscience is a pioneer in gallium nitride (GaN) technology as an Integrated Device Manufacturer (IDM) in China. According to its prospectus, Innoscience is one of the few companies globally to achieve mass production of 8-inch silicon-based GaN wafers. It also provides a full voltage spectrum of silicon-based GaN semiconductor products at an industrial scale.
Diverse Product Portfolio
Innoscience's products include:
- Discrete Devices: Covering voltage ranges from 15V to 1,200V.
- Integrated Circuits (ICs), Wafers, and Modules:
- Applications include consumer electronics, renewable energy, industrial electronics, automotive electronics, and data centers.
Path to Public Listing
With the successful hearing, Innoscience is poised to move closer to its listing date, marking a major step forward in scaling its operations and driving innovation in GaN-based semiconductor technologies.
